Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the
Second Quarter and Half year ended September 30, 2015 on Thursday,
October 29, 2015 after the Board Meeting. The results will be available
on the Company’s website www.drreddys.com.
|
|
|
|
|
|
|
Summary of Events
|
|
|
|
|
|
|
Event
|
|
|
Date and Time
|
|
|
Medium
|
Release of financial results
|
|
|
October 29th, after the Board Meeting
|
|
|
Email, Media, Company website, Business Wire
|
Earnings Call
|
|
|
October 29th, 6.30 PM IST / 9:00 AM EDT
|
|
|
Hosted by the Company (Details below)
|
Webcast of Earnings Call
|
|
|
October 29th, 6.30 PM IST / 9.00 AM EDT through Nov 2nd
|
|
|
URL available on Company’s website, www.drreddys.com
|
Transcript of the Earnings call
|
|
|
Will be available on the Company’s website
|
|
|
URL available on Company’s website, www.drreddys.com
|
|
|
|
|
|
|
|
Earnings Call
Following the release, the management of the Company will host an
earnings call to discuss the Company’s financial performance. (Dial
In and other details given below)
Audio Webcast
The audio webcast of the earnings call will be available to all
interested parties at www.drreddys.com.
Please visit the web site at least fifteen minutes ahead of the
scheduled start time to register and to download and install any
necessary audio software. Participants in the webcast can listen to the
proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through November 2, 2015. For
play back dial in phone No: 022 3065 2322, 022 61813322 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the
Company's website
|
Conference Dial-In Numbers
|
Primary Number:
|
|
+91 22 3960 0616
|
Secondary Number:
|
|
+91 22 6746 5826
|
The numbers listed above are universally accessible from all
networks and all countries.
|
Local Access Number:
|
|
6000 1221 Available in - Ahmedabad, Bangalore,
Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi, Goa, Guntur,
Gurgaon, Hyderabad, Indore, Jamshedpur, Kanpur, Kochi/Cochin,
Kolhapur, Kolkata, Nagpur, Noida, Patna, Pune, Raipur, Rajkot,
Surat, Trivandrum, Vadodara, Vijayawada Accessible from
all major carriers except BSNL/MTNL.
3940 3977
Available in Ahmedabad, Bangalore, Chandigarh, Chennai,
Kochi/Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune Accessible
from all carriers.
|
|
|
|
|
|
International Toll Free Number:
|
|
USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore:
800 101 2045 Hong Kong: 800 964 448
|
|
|
|
|
|
|
No password/pin number is necessary to dial in to any of the other
calls. As participation in the call is limited, early registration is
encouraged. The operator will provide instructions on asking questions
before and during the call.
About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is
an integrated pharmaceutical company, committed to accelerating access
to providing affordable and innovative medicines for healthier lives.
Through its three businesses - Pharmaceutical Services & Active
Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s
offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated
formulations. Our major therapeutic areas of focus are
gastro-intestinal, cardiovascular, diabetology, oncology, pain
management and anti-infectives. Dr. Reddy’s operates in markets across
the globe. Our major markets include – USA, Russia & CIS, Venezuela and
India. For more information, log on to: www.drreddys.com
Disclaimer: This press release may include statements of future
expectations and other forward-looking statements that are based on the
management’s current views and assumptions and involve known or unknown
risks and uncertainties that could cause actual results, performance or
events to differ materially from those expressed or implied in such
statements. In addition to statements which are forward-looking by
reason of context, the words "may", "will", "should", "expects",
"plans", "intends", "anticipates", "believes", "estimates", "predicts",
"potential", or "continue" and similar expressions identify
forward-looking statements. Actual results, performance or events may
differ materially from those in such statements due to without
limitation, (i) general economic conditions such as performance of
financial markets, credit defaults, currency exchange rates, interest
rates, persistency levels and frequency / severity of insured loss
events (ii) mortality and morbidity levels and trends, (iii) changing
levels of competition and general competitive factors, (iv) changes in
laws and regulations and in the policies of central banks and/or
governments, (v) the impact of acquisitions or reorganisation, including
related integration issues.
The company assumes no obligation to update any information contained
herein.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151019005636/en/
Copyright Business Wire 2015